Abeona Therapeutics Inc. priced an underwritten public offering of 5 million shares at $16 apiece to raise $80 million in gross proceeds.

The company granted underwriters a 30-day option to buy up to an additional 750,000 of the shares offered.

The offering is expected to close by Oct. 19, with Jefferies LLC acting as the lead book-running manager.

Abeona Therapeutics plans to use net proceeds for working capital and corporate purposes.

RBC Capital Markets is the joint book runner and Cantor Fitzgerald & Co. is the lead manager of the issue.

FBR Capital Markets & Co., H.C. Wainwright & Co., JonesTrading Institutional Services LLC and Maxim Group LLC are acting as co-managers for the offering.